Document is current
Any future updates will be listed below
-
Authors
Li, Haikuo https://orcid.org/0000-0003-3697-5662
Bao, Shuozhen https://orcid.org/0000-0002-9301-9952
Farzad, Negin https://orcid.org/0009-0002-5391-9363
Qin, Xiaoyu
Fung, Anthony A. https://orcid.org/0000-0003-1631-7451
Zhang, Di
Bai, Zhiliang https://orcid.org/0000-0002-3977-3057
Tao, Bo
Fan, Rong https://orcid.org/0000-0001-7805-8059
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (U54AG076043, U54AG079759, UG3CA257393, UH3CA257393, R01CA245313, RF1MH128876, U54CA274509, U01CA294514, U54CA268083)
This research was also supported by Packard Fellowship for Science and Engineering, Yale Stem Cell Center Chen Innovation Award.
- License Information
-
More Information
Article History
Received: 29 June 2024
Accepted: 15 November 2024
First Online: 21 March 2025
Competing interests
: R.F. is scientific founder of and advisor to IsoPlexis, Singleron Biotechnologies and AtlasXomics. The Yale University Provost’s Office reviewed and managed the interests of R.F. in accordance with the University’s conflict of interest policies. The other authors declare no competing interests.
